Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label
tabling member	label

Search

1127261

	registered interest
	date	16/05/2019
	answering body	Department for International Development
	answering dept id	20
	answering dept short name	International Development
	answering dept sort name	International Development
	hansard heading	Pneumococcal Diseases: Vaccination
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what plans they have to extend their engagement with the Advanced Market Commitment beyond the pilot for pneumococcal vaccine, run via Gavi, the Vaccine Alliance.
	tabling member printed	Lord Stevenson of Balmacara
	uin	HL15814
	answer	answer is ministerial correction date of answer 30/05/2019 answer text <p>The Advance Market Commitment (AMC) for Pneumococcal Vaccines is a dynamic financing instrument of Gavi, the Vaccine Alliance. Its objective is to reduce deaths from severe pneumonia by reducing the cost of the pneumococcal vaccine. The AMC does this by incentivising vaccine manufacturers and generating greater competition by encouraging additional manufacturers to the market. So far, 114 million children have been vaccinated with AMC-supported pneumococcal vaccines, saving 762,000 lives.</p><p> </p><p>DFID has committed $485 million to AMC from 2010 until 2020. The AMC has consistently delivered and performs very strongly. It scored an A+ in its last Annual Review. The current end date is scheduled for December 2020. DFID are currently reviewing vaccine demand projections and in discussions with other stakeholders whether an extension is required in order to attract new manufacturers and generate wider benefits. This review is in line with our approach to maximise effectiveness and ensure good value for money.</p> answering member printed Baroness Sugg question first answered 30/05/2019 12:54:28 answering member 4584 label Biography information for Baroness Sugg
	tabling member	4175 label Biography information for Lord Stevenson of Balmacara

1127262

	registered interest
	date	16/05/2019
	answering body	Department for International Development
	answering dept id	20
	answering dept short name	International Development
	answering dept sort name	International Development
	hansard heading	Pneumococcal Diseases: Vaccination
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what financial commitment they intend to make to the Advanced Market Commitment pilot for pneumococcal vaccine beyond 2020; and what estimate they have made of the expected total funding.
	tabling member printed	Lord Stevenson of Balmacara
	uin	HL15815
	answer	answer is ministerial correction date of answer 30/05/2019 answer text <p>The Advance Market Commitment (AMC) for Pneumococcal Vaccines is a dynamic financing instrument of Gavi, the Vaccine Alliance. Its objective is to reduce deaths from severe pneumonia by reducing the cost of the pneumococcal vaccine. The AMC does this by incentivising vaccine manufacturers and generating greater competition by encouraging additional manufacturers to the market. So far, 114 million children have been vaccinated with AMC-supported pneumococcal vaccines, saving 762,000 lives.</p><p> </p><p>The expected total funding for DFID’s contribution to AMC is $485 million from 2010 until the programme completes in 2020. To date, the UK have made no new financial commitments for AMC beyond completion of the programme in 2020. As part of the planning process for the next phase for Gavi, the UK and other stakeholders are exploring all innovative financing options which can improve global immunisation in poor countries.</p> answering member printed Baroness Sugg question first answered 30/05/2019 12:54:48 answering member 4584 label Biography information for Baroness Sugg
	tabling member	4175 label Biography information for Lord Stevenson of Balmacara